Ewing's sarcoma of bone: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

Annals of Oncology

Volumn 18, Issue SUPPL. 2, 2007, Pages

  Saeter, G ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b ESMO HEAD OFFICE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; VINCRISTINE;

ARTICLE; BONE MARROW BIOPSY; BONE METASTASIS; BONE RADIOGRAPHY; BONE SCINTISCANNING; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CHROMOSOME 11Q; CHROMOSOME 21Q; CHROMOSOME TRANSLOCATION 11; CHROMOSOME TRANSLOCATION 21; COMPUTER ASSISTED TOMOGRAPHY; CYTOGENETICS; DISEASE FREE SURVIVAL; EWING SARCOMA; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG METASTASIS; MICROSCOPY; MULTIPLE CYCLE TREATMENT; NEEDLE BIOPSY; ORTHOPEDIC SURGERY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE FRACTIONATION; RISK ASSESSMENT; TREATMENT PLANNING;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE NEOPLASMS; CHILD; COMBINED MODALITY THERAPY; HUMANS; NEOADJUVANT THERAPY; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY, ADJUVANT; SARCOMA, EWING'S;

EID: 54349116209     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdm048     Document Type: Article

References (5)

1. Grier HE. The Ewing family of tumors, Ewing's sarcoma and primitive neuroectodermal tumors. Pediatr Clin North Am 1997; 44: 991-1004.
2. Craft A, Cotterill S, Malcolm A et al. Ifosfamide-containing chemotherapy in Ewing's sarcoma: The Second United Kingdom Children's Cancer Study Group and the Medical research Council Ewing's Tumor Study. J Clin Oncol 1998; 16: 3628-3633.
3. Cotterill SJ, Ahrens S, Paulussen M et al. Prognostic factors in Ewing's tumor of bone: Analysis of 975 patents from the European Intergroup Cooperative Ewing's Sarcoma Study Group. J Clin Oncol 2000; 18: 3108-3114.
4. Dunst J, Jürgens H, Sauer R. Radiation therapy in Ewing's sarcoma: An update of the CESS 86 trial. Int J Radiat Oncol Biol Phys 1995; 32: 919-930.
5. Kushner BH, Meyers PA. How effecfive is dose-intensive/myeloablative therapy against Ewing's sarcoma/primitive neuroectodermal tumor metastatic to bone or bone marrow? The Memorial Sloan-Kettering experience and a literature review. J Clin Oncol 2001; 19: 870-880.